Mesothelin's minimal MUC16 binding moiety converts TR3 into a potent cancer therapeutic <i>via</i> hierarchical binding events at the plasma membrane
Yang Su(China Three Gorges Corporation (China)), Dirk Spitzer(Washington University in St. Louis)
Cited by 16
Related Papers
Conjugation to a SMAC mimetic potentiates sigma-2 ligand induced tumor cell death in ovarian cancer
|Molecular Cancer|2014|32